Physician profile
Nadejda Tihomirovs
NPI 1578159968
$2,701.20
in general payments reported to CMS, 2019-2025
17 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.65 · 2022: $685 · 2023: $623 · 2024: $863 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,994.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.57 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $621.62 | 2022-2025 | Xifaxan |
| Lilly USA, LLC | $481.69 | 2022-2023 | Jardiance, Emgality |
| Amgen INC. | $323.33 | 2022-2025 | Otezla, Repatha, Repatha |
| Xeris Pharmaceuticals, INC. | $125.00 | 2025 | Recorlev |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Kowa Pharmaceuticals America, INC. | $47.84 | 2025 | Zoryve |
| Corcept Therapeutics | $47.36 | 2024 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.35 | 2024-2025 | Jardiance |
| Scilex Pharmaceuticals INC. | $44.97 | 2025 | |
| Shield Therapeutics INC | $43.18 | 2025 | |
| Amarin Pharma, INC. | $39.85 | 2022 | |
| Merz North America, INC. | $38.65 | 2024 | |
| Ardelyx, INC. | $28.65 | 2025 | Ibsrela |
| Terumo Medical Corporation | $21.65 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.62 | 2023 | |
| Merck Sharp & Dohme LLC | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadejda Tihomirovs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.